Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease

107Citations
Citations of this article
81Readers
Mendeley users who have this article in their library.

Abstract

The molecular bases of Alzheimer's disease (AD) remain unclear. We used a lipidomic approach to identify lipid abnormalities in the brains of subjects with AD (N = 37) compared to age-matched controls (N = 17). The analyses revealed statistically detectable elevations in levels of non-esterified monounsaturated fatty acids (MUFAs) and mead acid (20:3n-9) in mid-frontal cortex, temporal cortex and hippocampus of AD patients. Further studies showed that brain mRNAs encoding for isoforms of the rate-limiting enzyme in MUFAs biosynthesis, stearoyl-CoA desaturase (SCD-1, SCD-5a and SCD-5b), were elevated in subjects with AD. The monounsaturated/saturated fatty acid ratio ('desaturation index') - displayed a strong negative correlation with measures of cognition: the Mini Mental State Examination test (r = -0.80; P = 0.0001) and the Boston Naming test (r = -0.57; P = 0.0071). Our results reveal a previously unrecognized role for the lipogenic enzyme SCD in AD. © 2011 Astarita et al.

Cite

CITATION STYLE

APA

Astarita, G., Jung, K. M., Vasilevko, V., DiPatrizio, N. V., Martin, S. K., Cribbs, D. H., … Piomelli, D. (2011). Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer’s disease. PLoS ONE, 6(10). https://doi.org/10.1371/journal.pone.0024777

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free